REG - AIM Biodexa Pharma - Cancellation - Biodexa Pharmaceuticals PLC
26/04/2023 08:15
For best results when printing this announcement, please click on link below: http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230426:nRSZ4197Xa&default-theme=true RNS Number : 4197X AIM 26 April 2023 NOTICE 26/04/2023 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM At the request of the company the following securities have been cancelled from trading on AIM with effect from the time and date of this notice. BIODEXA PHARMACEUTICALS PLC 549300GKR2G40H3QFY57 ORDINARY SHARES OF GBP0.02 EACH, FULLY PAID (BNGF1L7)(GB00BNGF1L75) MIDH PHAR/PAR VTG FPD 0.02 If you have any queries or require further information, please contact the company's nominated adviser. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com (mailto:rns@lseg.com) or visit www.rns.com (http://www.rns.com/) . RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy) . END AMOXELFLXZLXBBQ